1. Keeter, W. C., Ma, S., Stahr, N., Moriarty, A. K., & Galkina, E. V. (2022). Atherosclerosis and multi-organ-associated pathologies. Seminars in Immunopathology, 44, 363–374.
2. Kong, P., Cui, Z. Y., Huang, X. F., Zhang, D. D., Guo, R. J., & Han, M. (2022). Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal Transduction and Targeted Therapy, 7, 131.
3. Liu, D., Liu, J., Zhang, D., & Yang, W. (2022). Advances in relationship between cell senescence and atherosclerosis. Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang University Medical sciences., 51, 95–101.
4. Tuvali, O., Sella, G., Haberman, D., Cuciuc, V., & George, J. (2022). Colchicine in Atherosclerotic Vascular Disease: The Good, the Bad, and the Ugly. The Israel Medical Association Journal : IMAJ, 24, 191–197.
5. Chan, Y. H., & Ramji, D. P. (2022). Atherosclerosis: pathogenesis and key cellular processes current and emerging therapies, key challenges, and future research directions. Methods in Molecular Biology, 2419, 3–19.